PD-L1 expression is a predictive biomarker for CIK cell-based immunotherapy in postoperative patients with breast cancer

BACKGROUND: A sequential combination of radiochemotherapy/endocrinotherapy and cytokine-induced killer cell (CIK) infusion has been shown to be an effective therapy for post-mastectomy breast cancer based on statistical analysis of the patient population. However, whether an individual could obtain...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Zi-Qi, Zhao, Jing-Jing, Pan, Qiu-Zhong, Chen, Chang-Long, Liu, Yuan, Tang, Yan, Zhu, Qian, Weng, De-Sheng, Xia, Jian-Chuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712838/
https://www.ncbi.nlm.nih.gov/pubmed/31455411
http://dx.doi.org/10.1186/s40425-019-0696-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712838/
https://www.ncbi.nlm.nih.gov/pubmed/31455411
http://dx.doi.org/10.1186/s40425-019-0696-8

Ejemplares similares